Pre-order Enquiry
Request Free Sample
Global Musculoskeletal Medicine Market Research Report 2022
SKU ID : QYR-21414633 | Publishing Date : 03-Aug-2022 | No. of pages : 113
Detailed TOC of Global Musculoskeletal Medicine Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Dosage Form
1.2.1 Global Musculoskeletal Medicine Market Size Growth Rate by Dosage Form: 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Patch
1.2.4 Capsule
1.2.5 Suppositories
1.2.6 Injection
1.2.7 Suspension Agent
1.2.8 Emplastrum
1.2.9 Granules
1.2.10 Other
1.3 Market by Application
1.3.1 Global Musculoskeletal Medicine Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Orthopedic Analgesics
1.3.3 Antipyretic And Analgesic
1.3.4 Nonsteroidal Anti-Inflammatory Drugs
1.3.5 Drugs For Rheumatic Diseases
1.3.6 Gout Drug Resistance
1.3.7 Medication For Bruising Injuries
1.3.8 Myasthenia Gravis Medication
1.3.9 Slow Acting Antirheumatic Agent
1.3.10 Topical Administration For Joint And Muscle Pain
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Musculoskeletal Medicine Market Perspective (2017-2028)
2.2 Musculoskeletal Medicine Growth Trends by Region
2.2.1 Musculoskeletal Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Musculoskeletal Medicine Historic Market Size by Region (2017-2022)
2.2.3 Musculoskeletal Medicine Forecasted Market Size by Region (2023-2028)
2.3 Musculoskeletal Medicine Market Dynamics
2.3.1 Musculoskeletal Medicine Industry Trends
2.3.2 Musculoskeletal Medicine Market Drivers
2.3.3 Musculoskeletal Medicine Market Challenges
2.3.4 Musculoskeletal Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal Medicine Players by Revenue
3.1.1 Global Top Musculoskeletal Medicine Players by Revenue (2017-2022)
3.1.2 Global Musculoskeletal Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Musculoskeletal Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal Medicine Revenue
3.4 Global Musculoskeletal Medicine Market Concentration Ratio
3.4.1 Global Musculoskeletal Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Medicine Revenue in 2021
3.5 Musculoskeletal Medicine Key Players Head office and Area Served
3.6 Key Players Musculoskeletal Medicine Product Solution and Service
3.7 Date of Enter into Musculoskeletal Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Musculoskeletal Medicine Breakdown Data by Type
4.1 Global Musculoskeletal Medicine Historic Market Size by Type (2017-2022)
4.2 Global Musculoskeletal Medicine Forecasted Market Size by Type (2023-2028)
5 Musculoskeletal Medicine Breakdown Data by Application
5.1 Global Musculoskeletal Medicine Historic Market Size by Application (2017-2022)
5.2 Global Musculoskeletal Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Musculoskeletal Medicine Market Size (2017-2028)
6.2 North America Musculoskeletal Medicine Market Size by Country (2017-2022)
6.3 North America Musculoskeletal Medicine Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Musculoskeletal Medicine Market Size (2017-2028)
7.2 Europe Musculoskeletal Medicine Market Size by Country (2017-2022)
7.3 Europe Musculoskeletal Medicine Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Medicine Market Size (2017-2028)
8.2 Asia-Pacific Musculoskeletal Medicine Market Size by Country (2017-2022)
8.3 Asia-Pacific Musculoskeletal Medicine Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Musculoskeletal Medicine Market Size (2017-2028)
9.2 Latin America Musculoskeletal Medicine Market Size by Country (2017-2022)
9.3 Latin America Musculoskeletal Medicine Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Medicine Market Size (2017-2028)
10.2 Middle East & Africa Musculoskeletal Medicine Market Size by Country (2017-2022)
10.3 Middle East & Africa Musculoskeletal Medicine Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Mylan N.V.
11.1.1 Mylan N.V. Company Detail
11.1.2 Mylan N.V. Business Overview
11.1.3 Mylan N.V. Musculoskeletal Medicine Introduction
11.1.4 Mylan N.V. Revenue in Musculoskeletal Medicine Business (2017-2022)
11.1.5 Mylan N.V. Recent Development
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Teva Pharmaceutical Industries Ltd Company Detail
11.2.2 Teva Pharmaceutical Industries Ltd Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Introduction
11.2.4 Teva Pharmaceutical Industries Ltd Revenue in Musculoskeletal Medicine Business (2017-2022)
11.2.5 Teva Pharmaceutical Industries Ltd Recent Development
11.3 UCB S.A.
11.3.1 UCB S.A. Company Detail
11.3.2 UCB S.A. Business Overview
11.3.3 UCB S.A. Musculoskeletal Medicine Introduction
11.3.4 UCB S.A. Revenue in Musculoskeletal Medicine Business (2017-2022)
11.3.5 UCB S.A. Recent Development
11.4 Novartis Pharmaceuticals
11.4.1 Novartis Pharmaceuticals Company Detail
11.4.2 Novartis Pharmaceuticals Business Overview
11.4.3 Novartis Pharmaceuticals Musculoskeletal Medicine Introduction
11.4.4 Novartis Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022)
11.4.5 Novartis Pharmaceuticals Recent Development
11.5 Roche Inc
11.5.1 Roche Inc Company Detail
11.5.2 Roche Inc Business Overview
11.5.3 Roche Inc Musculoskeletal Medicine Introduction
11.5.4 Roche Inc Revenue in Musculoskeletal Medicine Business (2017-2022)
11.5.5 Roche Inc Recent Development
11.6 Hospira Inc
11.6.1 Hospira Inc Company Detail
11.6.2 Hospira Inc Business Overview
11.6.3 Hospira Inc Musculoskeletal Medicine Introduction
11.6.4 Hospira Inc Revenue in Musculoskeletal Medicine Business (2017-2022)
11.6.5 Hospira Inc Recent Development
11.7 Valeant Pharmaceuticals International, Inc
11.7.1 Valeant Pharmaceuticals International, Inc Company Detail
11.7.2 Valeant Pharmaceuticals International, Inc Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Introduction
11.7.4 Valeant Pharmaceuticals International, Inc Revenue in Musculoskeletal Medicine Business (2017-2022)
11.7.5 Valeant Pharmaceuticals International, Inc Recent Development
11.8 Dr. Reddy's Laboratories Ltd.
11.8.1 Dr. Reddy's Laboratories Ltd. Company Detail
11.8.2 Dr. Reddy's Laboratories Ltd. Business Overview
11.8.3 Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Introduction
11.8.4 Dr. Reddy's Laboratories Ltd. Revenue in Musculoskeletal Medicine Business (2017-2022)
11.8.5 Dr. Reddy's Laboratories Ltd. Recent Development
11.9 Sun Pharmaceutical Industries Ltd. Co. , Ltd
11.9.1 Sun Pharmaceutical Industries Ltd. Co. , Ltd Company Detail
11.9.2 Sun Pharmaceutical Industries Ltd. Co. , Ltd Business Overview
11.9.3 Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Introduction
11.9.4 Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue in Musculoskeletal Medicine Business (2017-2022)
11.9.5 Sun Pharmaceutical Industries Ltd. Co. , Ltd Recent Development
11.10 Sawai PharmaceuticalCo., Ltd
11.10.1 Sawai PharmaceuticalCo., Ltd Company Detail
11.10.2 Sawai PharmaceuticalCo., Ltd Business Overview
11.10.3 Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Introduction
11.10.4 Sawai PharmaceuticalCo., Ltd Revenue in Musculoskeletal Medicine Business (2017-2022)
11.10.5 Sawai PharmaceuticalCo., Ltd Recent Development
11.11 Endo International
11.11.1 Endo International Company Detail
11.11.2 Endo International Business Overview
11.11.3 Endo International Musculoskeletal Medicine Introduction
11.11.4 Endo International Revenue in Musculoskeletal Medicine Business (2017-2022)
11.11.5 Endo International Recent Development
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Detail
11.12.2 Hikma Pharmaceuticals Business Overview
11.12.3 Hikma Pharmaceuticals Musculoskeletal Medicine Introduction
11.12.4 Hikma Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022)
11.12.5 Hikma Pharmaceuticals Recent Development
11.13 Fresenius Kabi, LLC
11.13.1 Fresenius Kabi, LLC Company Detail
11.13.2 Fresenius Kabi, LLC Business Overview
11.13.3 Fresenius Kabi, LLC Musculoskeletal Medicine Introduction
11.13.4 Fresenius Kabi, LLC Revenue in Musculoskeletal Medicine Business (2017-2022)
11.13.5 Fresenius Kabi, LLC Recent Development
11.14 Boehringer Ingelheim
11.14.1 Boehringer Ingelheim Company Detail
11.14.2 Boehringer Ingelheim Business Overview
11.14.3 Boehringer Ingelheim Musculoskeletal Medicine Introduction
11.14.4 Boehringer Ingelheim Revenue in Musculoskeletal Medicine Business (2017-2022)
11.14.5 Boehringer Ingelheim Recent Development
11.15 Merck
11.15.1 Merck Company Detail
11.15.2 Merck Business Overview
11.15.3 Merck Musculoskeletal Medicine Introduction
11.15.4 Merck Revenue in Musculoskeletal Medicine Business (2017-2022)
11.15.5 Merck Recent Development
11.16 GSK
11.16.1 GSK Company Detail
11.16.2 GSK Business Overview
11.16.3 GSK Musculoskeletal Medicine Introduction
11.16.4 GSK Revenue in Musculoskeletal Medicine Business (2017-2022)
11.16.5 GSK Recent Development
11.17 Alter
11.17.1 Alter Company Detail
11.17.2 Alter Business Overview
11.17.3 Alter Musculoskeletal Medicine Introduction
11.17.4 Alter Revenue in Musculoskeletal Medicine Business (2017-2022)
11.17.5 Alter Recent Development
11.18 Bayer
11.18.1 Bayer Company Detail
11.18.2 Bayer Business Overview
11.18.3 Bayer Musculoskeletal Medicine Introduction
11.18.4 Bayer Revenue in Musculoskeletal Medicine Business (2017-2022)
11.18.5 Bayer Recent Development
11.19 Rafa Laboratories
11.19.1 Rafa Laboratories Company Detail
11.19.2 Rafa Laboratories Business Overview
11.19.3 Rafa Laboratories Musculoskeletal Medicine Introduction
11.19.4 Rafa Laboratories Revenue in Musculoskeletal Medicine Business (2017-2022)
11.19.5 Rafa Laboratories Recent Development
11.20 Grunenthal
11.20.1 Grunenthal Company Detail
11.20.2 Grunenthal Business Overview
11.20.3 Grunenthal Musculoskeletal Medicine Introduction
11.20.4 Grunenthal Revenue in Musculoskeletal Medicine Business (2017-2022)
11.20.5 Grunenthal Recent Development
11.21 Pfizer
11.21.1 Pfizer Company Detail
11.21.2 Pfizer Business Overview
11.21.3 Pfizer Musculoskeletal Medicine Introduction
11.21.4 Pfizer Revenue in Musculoskeletal Medicine Business (2017-2022)
11.21.5 Pfizer Recent Development
11.22 Sanofi
11.22.1 Sanofi Company Detail
11.22.2 Sanofi Business Overview
11.22.3 Sanofi Musculoskeletal Medicine Introduction
11.22.4 Sanofi Revenue in Musculoskeletal Medicine Business (2017-2022)
11.22.5 Sanofi Recent Development
11.23 Italfarmaco
11.23.1 Italfarmaco Company Detail
11.23.2 Italfarmaco Business Overview
11.23.3 Italfarmaco Musculoskeletal Medicine Introduction
11.23.4 Italfarmaco Revenue in Musculoskeletal Medicine Business (2017-2022)
11.23.5 Italfarmaco Recent Development
11.24 Martec USA LLC
11.24.1 Martec USA LLC Company Detail
11.24.2 Martec USA LLC Business Overview
11.24.3 Martec USA LLC Musculoskeletal Medicine Introduction
11.24.4 Martec USA LLC Revenue in Musculoskeletal Medicine Business (2017-2022)
11.24.5 Martec USA LLC Recent Development
11.25 Acorda Therapeutics
11.25.1 Acorda Therapeutics Company Detail
11.25.2 Acorda Therapeutics Business Overview
11.25.3 Acorda Therapeutics Musculoskeletal Medicine Introduction
11.25.4 Acorda Therapeutics Revenue in Musculoskeletal Medicine Business (2017-2022)
11.25.5 Acorda Therapeutics Recent Development
11.26 Apotex Inc
11.26.1 Apotex Inc Company Detail
11.26.2 Apotex Inc Business Overview
11.26.3 Apotex Inc Musculoskeletal Medicine Introduction
11.26.4 Apotex Inc Revenue in Musculoskeletal Medicine Business (2017-2022)
11.26.5 Apotex Inc Recent Development
11.27 CorePharma
11.27.1 CorePharma Company Detail
11.27.2 CorePharma Business Overview
11.27.3 CorePharma Musculoskeletal Medicine Introduction
11.27.4 CorePharma Revenue in Musculoskeletal Medicine Business (2017-2022)
11.27.5 CorePharma Recent Development
11.28 Helsinn
11.28.1 Helsinn Company Detail
11.28.2 Helsinn Business Overview
11.28.3 Helsinn Musculoskeletal Medicine Introduction
11.28.4 Helsinn Revenue in Musculoskeletal Medicine Business (2017-2022)
11.28.5 Helsinn Recent Development
11.29 Therabel
11.29.1 Therabel Company Detail
11.29.2 Therabel Business Overview
11.29.3 Therabel Musculoskeletal Medicine Introduction
11.29.4 Therabel Revenue in Musculoskeletal Medicine Business (2017-2022)
11.29.5 Therabel Recent Development
11.30 Sinopharm
11.30.1 Sinopharm Company Detail
11.30.2 Sinopharm Business Overview
11.30.3 Sinopharm Musculoskeletal Medicine Introduction
11.30.4 Sinopharm Revenue in Musculoskeletal Medicine Business (2017-2022)
11.30.5 Sinopharm Recent Development
11.31 Chinoin
11.31.1 Chinoin Company Detail
11.31.2 Chinoin Business Overview
11.31.3 Chinoin Musculoskeletal Medicine Introduction
11.31.4 Chinoin Revenue in Musculoskeletal Medicine Business (2017-2022)
11.31.5 Chinoin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Musculoskeletal Medicine Market Research Report 2022
List of TablesTable 1. Global Musculoskeletal Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tablets
Table 3. Key Players of Patch
Table 4. Key Players of Capsule
Table 5. Key Players of Suppositories
Table 6. Key Players of Injection
Table 7. Key Players of Suspension Agent
Table 8. Key Players of Emplastrum
Table 9. Key Players of Granules
Table 10. Key Players of Other
Table 11. Global Musculoskeletal Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Musculoskeletal Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 13. Global Musculoskeletal Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 14. Global Musculoskeletal Medicine Market Share by Region (2017-2022)
Table 15. Global Musculoskeletal Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 16. Global Musculoskeletal Medicine Market Share by Region (2023-2028)
Table 17. Musculoskeletal Medicine Market Trends
Table 18. Musculoskeletal Medicine Market Drivers
Table 19. Musculoskeletal Medicine Market Challenges
Table 20. Musculoskeletal Medicine Market Restraints
Table 21. Global Musculoskeletal Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 22. Global Musculoskeletal Medicine Market Share by Players (2017-2022)
Table 23. Global Top Musculoskeletal Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Medicine as of 2021)
Table 24. Ranking of Global Top Musculoskeletal Medicine Companies by Revenue (US$ Million) in 2021
Table 25. Global 5 Largest Players Market Share by Musculoskeletal Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Musculoskeletal Medicine Product Solution and Service
Table 28. Date of Enter into Musculoskeletal Medicine Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Musculoskeletal Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 31. Global Musculoskeletal Medicine Revenue Market Share by Type (2017-2022)
Table 32. Global Musculoskeletal Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 33. Global Musculoskeletal Medicine Revenue Market Share by Type (2023-2028)
Table 34. Global Musculoskeletal Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 35. Global Musculoskeletal Medicine Revenue Market Share by Application (2017-2022)
Table 36. Global Musculoskeletal Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 37. Global Musculoskeletal Medicine Revenue Market Share by Application (2023-2028)
Table 38. North America Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 41. Europe Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 42. Asia-Pacific Musculoskeletal Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 43. Asia-Pacific Musculoskeletal Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 44. Latin America Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 45. Latin America Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 46. Middle East & Africa Musculoskeletal Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 47. Middle East & Africa Musculoskeletal Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 48. Mylan N.V. Company Detail
Table 49. Mylan N.V. Business Overview
Table 50. Mylan N.V. Musculoskeletal Medicine Product
Table 51. Mylan N.V. Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 52. Mylan N.V. Recent Development
Table 53. Teva Pharmaceutical Industries Ltd Company Detail
Table 54. Teva Pharmaceutical Industries Ltd Business Overview
Table 55. Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Product
Table 56. Teva Pharmaceutical Industries Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 57. Teva Pharmaceutical Industries Ltd Recent Development
Table 58. UCB S.A. Company Detail
Table 59. UCB S.A. Business Overview
Table 60. UCB S.A. Musculoskeletal Medicine Product
Table 61. UCB S.A. Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 62. UCB S.A. Recent Development
Table 63. Novartis Pharmaceuticals Company Detail
Table 64. Novartis Pharmaceuticals Business Overview
Table 65. Novartis Pharmaceuticals Musculoskeletal Medicine Product
Table 66. Novartis Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 67. Novartis Pharmaceuticals Recent Development
Table 68. Roche Inc Company Detail
Table 69. Roche Inc Business Overview
Table 70. Roche Inc Musculoskeletal Medicine Product
Table 71. Roche Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 72. Roche Inc Recent Development
Table 73. Hospira Inc Company Detail
Table 74. Hospira Inc Business Overview
Table 75. Hospira Inc Musculoskeletal Medicine Product
Table 76. Hospira Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 77. Hospira Inc Recent Development
Table 78. Valeant Pharmaceuticals International, Inc Company Detail
Table 79. Valeant Pharmaceuticals International, Inc Business Overview
Table 80. Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Product
Table 81. Valeant Pharmaceuticals International, Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 82. Valeant Pharmaceuticals International, Inc Recent Development
Table 83. Dr. Reddy's Laboratories Ltd. Company Detail
Table 84. Dr. Reddy's Laboratories Ltd. Business Overview
Table 85. Dr. Reddy's Laboratories Ltd. Musculoskeletal Medicine Product
Table 86. Dr. Reddy's Laboratories Ltd. Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 87. Dr. Reddy's Laboratories Ltd. Recent Development
Table 88. Sun Pharmaceutical Industries Ltd. Co. , Ltd Company Detail
Table 89. Sun Pharmaceutical Industries Ltd. Co. , Ltd Business Overview
Table 90. Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Product
Table 91. Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 92. Sun Pharmaceutical Industries Ltd. Co. , Ltd Recent Development
Table 93. Sawai PharmaceuticalCo., Ltd Company Detail
Table 94. Sawai PharmaceuticalCo., Ltd Business Overview
Table 95. Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Product
Table 96. Sawai PharmaceuticalCo., Ltd Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 97. Sawai PharmaceuticalCo., Ltd Recent Development
Table 98. Endo International Company Detail
Table 99. Endo International Business Overview
Table 100. Endo International Musculoskeletal MedicineProduct
Table 101. Endo International Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 102. Endo International Recent Development
Table 103. Hikma Pharmaceuticals Company Detail
Table 104. Hikma Pharmaceuticals Business Overview
Table 105. Hikma Pharmaceuticals Musculoskeletal MedicineProduct
Table 106. Hikma Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 107. Hikma Pharmaceuticals Recent Development
Table 108. Fresenius Kabi, LLC Company Detail
Table 109. Fresenius Kabi, LLC Business Overview
Table 110. Fresenius Kabi, LLC Musculoskeletal MedicineProduct
Table 111. Fresenius Kabi, LLC Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 112. Fresenius Kabi, LLC Recent Development
Table 113. Boehringer Ingelheim Company Detail
Table 114. Boehringer Ingelheim Business Overview
Table 115. Boehringer Ingelheim Musculoskeletal MedicineProduct
Table 116. Boehringer Ingelheim Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 117. Boehringer Ingelheim Recent Development
Table 118. Merck Company Detail
Table 119. Merck Business Overview
Table 120. Merck Musculoskeletal MedicineProduct
Table 121. Merck Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 122. Merck Recent Development
Table 123. GSK Company Detail
Table 124. GSK Business Overview
Table 125. GSK Musculoskeletal MedicineProduct
Table 126. GSK Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 127. GSK Recent Development
Table 128. Alter Company Detail
Table 129. Alter Business Overview
Table 130. Alter Musculoskeletal MedicineProduct
Table 131. Alter Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 132. Alter Recent Development
Table 133. Bayer Company Detail
Table 134. Bayer Business Overview
Table 135. Bayer Musculoskeletal MedicineProduct
Table 136. Bayer Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 137. Bayer Recent Development
Table 138. Rafa Laboratories Company Detail
Table 139. Rafa Laboratories Business Overview
Table 140. Rafa Laboratories Musculoskeletal MedicineProduct
Table 141. Rafa Laboratories Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 142. Rafa Laboratories Recent Development
Table 143. Grunenthal Company Detail
Table 144. Grunenthal Business Overview
Table 145. Grunenthal Musculoskeletal MedicineProduct
Table 146. Grunenthal Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 147. Grunenthal Recent Development
Table 148. Pfizer Company Detail
Table 149. Pfizer Business Overview
Table 150. Pfizer Musculoskeletal MedicineProduct
Table 151. Pfizer Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 152. Pfizer Recent Development
Table 153. Sanofi Company Detail
Table 154. Sanofi Business Overview
Table 155. Sanofi Musculoskeletal MedicineProduct
Table 156. Sanofi Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 157. Sanofi Recent Development
Table 158. Italfarmaco Company Detail
Table 159. Italfarmaco Business Overview
Table 160. Italfarmaco Musculoskeletal MedicineProduct
Table 161. Italfarmaco Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 162. Italfarmaco Recent Development
Table 163. Martec USA LLC Company Detail
Table 164. Martec USA LLC Business Overview
Table 165. Martec USA LLC Musculoskeletal MedicineProduct
Table 166. Martec USA LLC Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 167. Martec USA LLC Recent Development
Table 168. Acorda Therapeutics Company Detail
Table 169. Acorda Therapeutics Business Overview
Table 170. Acorda Therapeutics Musculoskeletal MedicineProduct
Table 171. Acorda Therapeutics Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 172. Acorda Therapeutics Recent Development
Table 173. Apotex Inc Company Detail
Table 174. Apotex Inc Business Overview
Table 175. Apotex Inc Musculoskeletal MedicineProduct
Table 176. Apotex Inc Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 177. Apotex Inc Recent Development
Table 178. CorePharma Company Detail
Table 179. CorePharma Business Overview
Table 180. CorePharma Musculoskeletal MedicineProduct
Table 181. CorePharma Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 182. CorePharma Recent Development
Table 183. Helsinn Company Detail
Table 184. Helsinn Business Overview
Table 185. Helsinn Musculoskeletal MedicineProduct
Table 186. Helsinn Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 187. Helsinn Recent Development
Table 188. Therabel Company Detail
Table 189. Therabel Business Overview
Table 190. Therabel Musculoskeletal MedicineProduct
Table 191. Therabel Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 192. Therabel Recent Development
Table 193. Sinopharm Company Detail
Table 194. Sinopharm Business Overview
Table 195. Sinopharm Musculoskeletal MedicineProduct
Table 196. Sinopharm Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 197. Sinopharm Recent Development
Table 198. Chinoin Company Detail
Table 199. Chinoin Business Overview
Table 200. Chinoin Musculoskeletal Medicine Product
Table 201. Chinoin Revenue in Musculoskeletal Medicine Business (2017-2022) & (US$ Million)
Table 202. Chinoin Recent Development
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Musculoskeletal Medicine Market Share by Type: 2021 VS 2028
Figure 2. Tablets Features
Figure 3. Patch Features
Figure 4. Capsule Features
Figure 5. Suppositories Features
Figure 6. Injection Features
Figure 7. Suspension Agent Features
Figure 8. Emplastrum Features
Figure 9. Granules Features
Figure 10. Other Features
Figure 11. Global Musculoskeletal Medicine Market Share by Application in 2021 & 2028
Figure 12. Orthopedic Analgesics Case Studies
Figure 13. Antipyretic And Analgesic Case Studies
Figure 14. Nonsteroidal Anti-Inflammatory Drugs Case Studies
Figure 15. Drugs For Rheumatic Diseases Case Studies
Figure 16. Gout Drug Resistance Case Studies
Figure 17. Medication For Bruising Injuries Case Studies
Figure 18. Myasthenia Gravis Medication Case Studies
Figure 19. Slow Acting Antirheumatic Agent Case Studies
Figure 20. Topical Administration For Joint And Muscle Pain Case Studies
Figure 21. Other Case Studies
Figure 22. Musculoskeletal Medicine Report Years Considered
Figure 23. Global Musculoskeletal Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 24. Global Musculoskeletal Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 25. Global Musculoskeletal Medicine Market Share by Region: 2021 VS 2028
Figure 26. Global Musculoskeletal Medicine Market Share by Players in 2021
Figure 27. Global Top Musculoskeletal Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Medicine as of 2021)
Figure 28. The Top 10 and 5 Players Market Share by Musculoskeletal Medicine Revenue in 2021
Figure 29. North America Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. North America Musculoskeletal Medicine Market Share by Country (2017-2028)
Figure 31. United States Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Canada Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Europe Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Europe Musculoskeletal Medicine Market Share by Country (2017-2028)
Figure 35. Germany Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. France Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. U.K. Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Italy Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Russia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Nordic Countries Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Asia-Pacific Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Asia-Pacific Musculoskeletal Medicine Market Share by Region (2017-2028)
Figure 43. China Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Japan Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. South Korea Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Southeast Asia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. India Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Australia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Latin America Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Latin America Musculoskeletal Medicine Market Share by Country (2017-2028)
Figure 51. Mexico Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Musculoskeletal Medicine Market Share by Country (2017-2028)
Figure 55. Turkey Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Musculoskeletal Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Mylan N.V. Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 58. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 59. UCB S.A. Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 60. Novartis Pharmaceuticals Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 61. Roche Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 62. Hospira Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 63. Valeant Pharmaceuticals International, Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 64. Dr. Reddy's Laboratories Ltd. Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 65. Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 66. Sawai PharmaceuticalCo., Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 67. Endo International Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 68. Hikma Pharmaceuticals Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 69. Fresenius Kabi, LLC Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 70. Boehringer Ingelheim Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 71. Merck Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 72. GSK Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 73. Alter Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 74. Bayer Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 75. Rafa Laboratories Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 76. Grunenthal Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 77. Pfizer Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 78. Sanofi Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 79. Italfarmaco Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 80. Martec USA LLC Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 81. Acorda Therapeutics Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 82. Apotex Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 83. CorePharma Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 84. Helsinn Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 85. Therabel Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 86. Sinopharm Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 87. Chinoin Revenue Growth Rate in Musculoskeletal Medicine Business (2017-2022)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Keyplayers in Global Musculoskeletal Medicine Market Research Report 2022
Mylan N.V.Teva Pharmaceutical Industries Ltd
UCB S.A.
Novartis Pharmaceuticals
Roche Inc
Hospira Inc
Valeant Pharmaceuticals International, Inc
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd. Co. , Ltd
Sawai PharmaceuticalCo., Ltd
Endo International
Hikma Pharmaceuticals
Fresenius Kabi, LLC
Boehringer Ingelheim
Merck
GSK
Alter
Bayer
Rafa Laboratories
Grunenthal
Pfizer
Sanofi
Italfarmaco
Martec USA LLC
Acorda Therapeutics
Apotex Inc
CorePharma
Helsinn
Therabel
Sinopharm
Chinoin
Request Sample
Request Discount
